Maintain Professional Standards Recognize scope of practice limitations Provide evidence-based information without overpromising Prioritize client safety and informed decision-making Collaborate with medical professionals for optimal client outcomes The landscape of metabolic health is being transformed by innovative peptide therapies like cagrilintide and tirzepatide
Here we compare the published data from the STEP-1, SURMOUNT-1, and TRIUMPH-4 trials without marketing spin: -14,9% for semaglutide, -20,9% for the tirzepatide-28,7% for the retatrutideThe retatrutide vs tirzepatide vs semaglutide comparison also incorporates tolerance (dysesthesia 20,9% at the 12 mg dose level of retatrutide), pleiotropic effects 2024-2025 (apnea, heart failure, MASLD), and the updated regulatory status in France 2026
Quinoline drugs at 100 M also did not induce major short-term effects on the E GSH (Fig
A peptide credited with somnogenic, analgesic, anti-stress, endocrine, and anti-withdrawal actions, with no receptor and no established pathway linking any of them, is a peptide whose reported activity has never been localized
Animal studies using euglycemic clamp techniques, the gold standard for insulin sensitivity assessment, confirmed that chronic AOD-9604 treatment produced no adverse effects on insulin sensitivity
